{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:33:59Z","timestamp":1793036039691,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology &amp; Behavior"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.physbeh.2024.114644","type":"journal-article","created":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T14:22:00Z","timestamp":1721571720000},"page":"114644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism"],"prefix":"10.1016","volume":"284","author":[{"given":"Zengbing","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man P.","family":"Ngan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Y.H","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longlong","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze Wa","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Lovati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Pietra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Rudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2024.114644_bib0001","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tem.2019.09.006","article-title":"Ghrelin signaling: goat and GHS-R1a take a LEAP in complexity","volume":"31","author":"Abizaid","year":"2020","journal-title":"Trends. Endocrinol. Metab."},{"key":"10.1016\/j.physbeh.2024.114644_bib0002","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/13510002.2021.1913374","article-title":"Potentiality of ghrelin as antioxidant and protective agent","volume":"26","author":"Akki","year":"2021","journal-title":"Redox. Rep."},{"key":"10.1016\/j.physbeh.2024.114644_bib0003","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuropharm.2019.01.001","article-title":"Ghrelin and food reward","volume":"148","author":"Al Massadi","year":"2019","journal-title":"Neuropharmacol."},{"key":"10.1016\/j.physbeh.2024.114644_bib0004","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000346042","article-title":"The ghrelin receptors (GHS-R1a and GHS-R1b)","volume":"25","author":"Albarr\u00e1n-Zeckler","year":"2013","journal-title":"Endocr. Dev."},{"key":"10.1016\/j.physbeh.2024.114644_bib0005","series-title":"Management of Chemotherapy-Induced Nausea and Vomiting: New Agents and New Uses of Current Agents","first-page":"5","article-title":"The physiology and pharmacology of nausea and vomiting induced by anticancer chemotherapy in humans","author":"Andrews","year":"2016"},{"key":"10.1016\/j.physbeh.2024.114644_bib0006","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1124\/jpet.102.034827","article-title":"Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure","volume":"302","author":"Banks","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.physbeh.2024.114644_bib0007","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s00384-014-2030-8","article-title":"Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients","volume":"29","author":"Beck","year":"2014","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.physbeh.2024.114644_bib0008","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1210\/jc.2003-031267","article-title":"Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans","volume":"89","author":"Callahan","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.physbeh.2024.114644_bib0009","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2217\/fon.14.14","article-title":"Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome","volume":"10","author":"Currow","year":"2014","journal-title":"Future Oncol."},{"key":"10.1016\/j.physbeh.2024.114644_bib0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/1097-0029(20010101)52:1<83::AID-JEMT10>3.0.CO;2-N","article-title":"Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus","volume":"52","author":"Ghersi-Egea","year":"2001","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.physbeh.2024.114644_bib0011","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.peptides.2011.07.015","article-title":"Ghrelin inhibited serotonin release from hippocampal slices","volume":"32","author":"Ghersi","year":"2011","journal-title":"Peptides.Peptides."},{"key":"10.1016\/j.physbeh.2024.114644_bib0012","first-page":"3480","article-title":"Involvement of ghrelin in nucleus tractus solitaries on gastric signal afferent and gastric motility in cisplatin-treated rats","volume":"20","author":"Gong","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.physbeh.2024.114644_bib0013","article-title":"Chemotherapy-Induced Nausea and Vomiting: pathogenesis, Recommendations, and New Trends","volume":"26","author":"Gupta","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.physbeh.2024.114644_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182659","article-title":"Impact of ghrelin on body composition and muscle function in a long-term rodent model of critical illness","volume":"12","author":"Hill","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.physbeh.2024.114644_bib0015","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1002\/cncr.27430","article-title":"Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: a prospective, randomized, placebo-controlled phase 2 study","volume":"118","author":"Hiura","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.physbeh.2024.114644_bib0016","doi-asserted-by":"crossref","first-page":"R1375","DOI":"10.1152\/ajpregu.00284.2009","article-title":"Chemotherapy-induced kaolin intake is increased by lesion of the lateral parabrachial nucleus of the rat","volume":"297","author":"Horn","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.physbeh.2024.114644_bib0017","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/10998004211000443","article-title":"Olanzapine administration reduces chemotherapy-induced nausea behavior in rats","volume":"23","author":"Jaime-Lara","year":"2021","journal-title":"Biol. Res. Nurs."},{"key":"10.1016\/j.physbeh.2024.114644_bib0018","unstructured":"Jim\u00e9nez-Reina, L., Ca\u00f1ete, R., Torre, M.J., Bernal, J., 2002. Chronic in vivo ipamorelin treatment stimulates body weight gain and growth hormone (GH) release in vitro in young female rats. Eur. J. anatomy, ISSN 1136-4890, Vol. 6, N. 1, 2002, pags. 37\u2013466."},{"key":"10.1016\/j.physbeh.2024.114644_bib0019","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/gut.2005.065896","article-title":"Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro","volume":"54","author":"Kitazawa","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.physbeh.2024.114644_bib0020","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2024.114644_bib0021","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1152\/physrev.00012.2004","article-title":"Ghrelin: structure and function","volume":"85","author":"Kojima","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.physbeh.2024.114644_bib0022","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00280-005-0179-0","article-title":"Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents","volume":"58","author":"Liu","year":"2006","journal-title":"Cancer Chemother Pharmacol."},{"key":"10.1016\/j.physbeh.2024.114644_bib0023","doi-asserted-by":"crossref","first-page":"98691","DOI":"10.18632\/oncotarget.21859","article-title":"Gastric myoelectric activity during cisplatin-induced acute and delayed emesis reveals a temporal impairment of slow waves in ferrets: effects not reversed by the GLP-1 receptor antagonist, exendin (9-39)","volume":"8","author":"Lu","year":"2017","journal-title":"Oncotarget.Oncotarget."},{"key":"10.1016\/j.physbeh.2024.114644_bib0024","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12967-014-0327-6","article-title":"Differential hypoglycaemic, anorectic, autonomic and emetic effects of the glucagon-like peptide receptor agonist, exendin-4, in the conscious telemetered ferret","volume":"12","author":"Lu","year":"2014","journal-title":"J Transl Med"},{"issue":"Suppl","key":"10.1016\/j.physbeh.2024.114644_bib0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2044.1994.tb03575.x","article-title":"The physiology and pharmacology of postoperative nausea and vomiting","volume":"49","author":"Naylor","year":"1994","journal-title":"Anaesthesia"},{"key":"10.1016\/j.physbeh.2024.114644_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1248\/bpbreports.7.1_1","article-title":"Drug repositioning study on the antiemetic efficacy of anamorelin for cisplatin-induced nausea and vomiting in rats","volume":"7","author":"Nishino","year":"2024","journal-title":"BPB Reports"},{"key":"10.1016\/j.physbeh.2024.114644_bib0027","doi-asserted-by":"crossref","first-page":"G1376","DOI":"10.1152\/ajpgi.00536.2006","article-title":"Ghrelin selectively reduces mechanosensitivity of upper gastrointestinal vagal afferents","volume":"292","author":"Page","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver. Physiol."},{"key":"10.1016\/j.physbeh.2024.114644_bib0028","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2045-8118-8-7","article-title":"Drug transport in brain via the cerebrospinal fluid","volume":"8","author":"Pardridge","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.physbeh.2024.114644_bib0029","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1517\/17425247.2016.1171315","article-title":"CSF, blood-brain barrier, and brain drug delivery","volume":"13","author":"Pardridge","year":"2016","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.physbeh.2024.114644_bib0030","first-page":"2340","article-title":"Systematic review and meta-analysis of pre-clinical research: the need for reporting guidelines","volume":"32","author":"Percie du Sert","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.physbeh.2024.114644_bib0031","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13539-014-0159-5","article-title":"Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile","volume":"5","author":"Pietra","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.physbeh.2024.114644_bib0032","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1530\/eje.0.1390552","article-title":"Ipamorelin, the first selective growth hormone secretagogue","volume":"139","author":"Raun","year":"1998","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.physbeh.2024.114644_bib0033","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3389\/fphar.2018.00869","volume":"9","author":"Rudd","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.physbeh.2024.114644_bib0034","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1476-5381.1996.tb15388.x","article-title":"An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret","volume":"118","author":"Rudd","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2024.114644_bib0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neulet.2005.08.062","article-title":"Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin","volume":"392","author":"Rudd","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.physbeh.2024.114644_bib0036","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/164_2016_104","article-title":"Ghrelin and motilin control systems in GI physiology and therapeutics","volume":"239","author":"Sanger","year":"2017","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.physbeh.2024.114644_bib0037","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jcf.2019.01.010","article-title":"Incretin dysfunction and hyperglycemia in cystic fibrosis: role of acyl-ghrelin","volume":"18","author":"Sun","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.physbeh.2024.114644_bib0038","doi-asserted-by":"crossref","first-page":"15257","DOI":"10.1038\/s41598-023-42446-x","article-title":"The efficacy and safety of anamorelin for patients with cancer-related anorexia\/cachexia syndrome: a systematic review and meta-analysis","volume":"13","author":"Taniguchi","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.physbeh.2024.114644_bib0039","first-page":"131","article-title":"Involvement of free radicals in cisplatin-induced emesis in suncus murinus","volume":"248","author":"Torii","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2024.114644_bib0040","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/bph.14924","article-title":"The brain-penetrating, orally bioavailable, ghrelin receptor agonist HM01 ameliorates motion-induced emesis in suncus murinus (house musk shrew)","volume":"177","author":"Tu","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2024.114644_bib0041","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1124\/jpet.108.149211","article-title":"Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileus","volume":"329","author":"Venkova","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.physbeh.2024.114644_bib0042","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/gerona\/gly256","article-title":"Protective effects of ghrelin on fasting-induced muscle atrophy in aging mice","volume":"75","author":"Wu","year":"2020","journal-title":"J. Gerontol. a Biol. Sci. Med. Sci."},{"key":"10.1016\/j.physbeh.2024.114644_bib0043","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal. Transduct. Target. Ther."}],"container-title":["Physiology &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938424001926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938424001926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T15:02:19Z","timestamp":1723302139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938424001926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":43,"alternative-id":["S0031938424001926"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2024.114644","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2024.114644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114644"}}